Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2016
Home
2016
February 23, 2023
Published by
Dominic Burg
on
February 23, 2023
Categories
Results of Institutional Entitlement Offer
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 4C – quarterly
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appointment of Elizabeth Masamune
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Investor Briefing
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 4D and Half Year Accounts
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid to Refinance RnD Loan
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Transcript of Cellmid Investor Briefing
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Fourth Midkine Symposium to be held in Budapest
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Midkine Strategy Update
1
2
3
4
5
6
Next page
